Advertisement News Archives - Page 1740 of 5245 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 19, 2026

FDA approves Regeneron’s Livsayis for generalised myasthenia gravis

The US Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Livsayis (cemdisiran) to treat generalised myasthenia gravis (gMG) in adult patients positive for anti-acetylcholine receptor (AChR) antibodies.

FDA approves Regeneron’s Livsayis for generalised myasthenia gravis